We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
-$230M
Cap. Flow
-$211M
Cap. Flow %
-106.78%
Top 10 Hldgs %
42%
Holding
45
New
2
Increased
13
Reduced
11
Closed
12

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$5.64M
2
PODD icon
Insulet
PODD
+$4.48M
3
HCA icon
HCA Healthcare
HCA
+$4.1M
4
UNH icon
UnitedHealth
UNH
+$2.46M
5
AVTR icon
Avantor
AVTR
+$2.23M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12M
2
BDX icon
Becton Dickinson
BDX
+$7.92M
3
ELV icon
Elevance Health
ELV
+$6.66M
4
ABT icon
Abbott
ABT
+$6.54M
5
MRK icon
Merck
MRK
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 96.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$89.5B
$9.84M 4.97%
40,000
+15,000
+60% +$4.1M
THC icon
2
Tenet Healthcare
THC
$21.1B
$9.22M 4.66%
140,000
– –
HUM icon
3
Humana
HUM
$46.2B
$8.51M 4.3%
17,500
– –
BSX icon
4
Boston Scientific
BSX
$71.5B
$8.45M 4.27%
160,000
– –
NVO
5
Novo Nordisk
NVO
$209B
$8.19M 4.14%
90,000
-10,000
-10% -$881K
UHS icon
6
Universal Health Services
UHS
$10.5B
$8.17M 4.13%
65,000
+12,500
+24% +$1.71M
LLY icon
7
Eli Lilly
LLY
$1.06T
$8.06M 4.07%
15,000
-2,500
-14% -$1.29M
MCK icon
8
McKesson
MCK
$101B
$7.61M 3.85%
17,500
– –
UNH icon
9
UnitedHealth
UNH
$370B
$7.56M 3.82%
15,000
+5,000
+50% +$2.46M
SYK icon
10
Stryker
SYK
$130B
$7.51M 3.8%
27,500
+2,500
+10% +$717K
XBI icon
11
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$7.3M 3.69%
100,000
-150,000
-60% -$12M
CI icon
12
Cigna
CI
$74.6B
$7.15M 3.61%
25,000
+5,000
+25% +$1.43M
DHR icon
13
Danaher
DHR
$144B
$6.82M 3.45%
31,020
+2,820
+10% +$629K
ISRG icon
14
Intuitive Surgical
ISRG
$134B
$6.58M 3.32%
22,500
– –
COR icon
15
Cencora
COR
$61.2B
$6.3M 3.18%
35,000
-5,000
-13% -$923K
MDT icon
16
Medtronic
MDT
$112B
$6.27M 3.17%
80,000
+20,000
+33% +$1.67M
EHC icon
17
Encompass Health
EHC
$12.4B
$6.04M 3.05%
90,000
-9,976
-10% -$686K
ZBH icon
18
Zimmer Biomet
ZBH
$18.4B
$5.61M 2.84%
50,000
-5,000
-9% -$635K
TMO icon
19
Thermo Fisher Scientific
TMO
$220B
$5.32M 2.69%
10,500
+3,000
+40% +$1.6M
ACHC icon
20
Acadia Healthcare
ACHC
$2.94B
$5.27M 2.66%
75,000
+15,000
+25% +$1.12M
CAH icon
21
Cardinal Health
CAH
$55.4B
$5.21M 2.63%
60,000
-25,000
-29% -$2.26M
SGRY icon
22
Surgery Partners
SGRY
$2.03B
$5.12M 2.59%
175,000
– –
SEM
23
DELISTED
Select Medical
SEM
$4.86M 2.46%
356,989
+4,349
+1% +$67.2K
BAX icon
24
Baxter International
BAX
$14.2B
$4.72M 2.38%
125,000
-35,000
-22% -$1.49M
DXCM icon
25
DexCom
DXCM
$32B
$4.67M 2.36%
+50,000
New +$5.64M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q3 2023 Portfolio in Review

As of Q3 2023, Sivik Global Healthcare held 45 positions worth $198M, down 54% from $428M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sivik Global Healthcare withdrew a net $211M in Q3 2023, closing 12 positions and reducing 11 holdings. Its most notable exit was Becton Dickinson, an estimated $7.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 54% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in DexCom worth $4.67M.

  • Sivik Global Healthcare's largest Q3 2023 buy was DexCom: 50,000 shares worth $4.67M.
  • Sivik Global Healthcare added most to HCA Healthcare in Q3 2023, an estimated $4.1M increase.
  • Sivik Global Healthcare's biggest Q3 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $12M.
  • Sivik Global Healthcare fully exited Becton Dickinson in Q3 2023, selling an estimated $7.92M.
  • Sivik Global Healthcare's ten largest holdings make up 42% of its $198M portfolio in Q3 2023.
  • Sivik Global Healthcare opened 2 new positions and closed 12 in Q3 2023.
  • Sivik Global Healthcare's portfolio value fell 54% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q3 2023, filed 7 Nov 2023.